GLP-1 Weight Loss Injection (Subcutaneous)
FDA-Approved Weight Loss Treatment for Long-Term Results
Clinically proven to help reduce body weight by 15-20% in patients with obesity.
Helps control appetite, reduce food cravings, and increase satiety, supporting long-term weight management.
FDA-approved for the treatment of obesity and weight-related conditions like type 2 diabetes.
Administered through an easy-to-use weekly subcutaneous injection, improving treatment adherence.
Select a plan
One-time purchase
394.95€
Recommended Usage
Ingredients
Dosage
GLP-1 Weight Loss Injection is administered as a once-weekly subcutaneous injection. Initial dose starts at 0.25mg, gradually increased to 1mg over several weeks based on individual tolerance and response.
Duration
Patients typically see noticeable weight loss within 12-16 weeks, with continued use recommended for long-term weight management and sustainable results.
80%
of clinical trial participants using GLP-1 Weight Loss Injection experienced significant weight loss within 6 months.
Important Safety Information:
GLP-1 Weight Loss Injection is contraindicated in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It is also not recommended during pregnancy or breastfeeding. Common side effects may include nausea, vomiting, diarrhea, and stomach pain. More serious side effects, including pancreatitis, kidney problems, and gallbladder disease, have been reported in rare cases. Consult with your healthcare provider to determine if GLP-1 Weight Loss Injection is right for you.